NO20060445L - Fast farmasoytisk preparat omfattende amisulprid - Google Patents

Fast farmasoytisk preparat omfattende amisulprid

Info

Publication number
NO20060445L
NO20060445L NO20060445A NO20060445A NO20060445L NO 20060445 L NO20060445 L NO 20060445L NO 20060445 A NO20060445 A NO 20060445A NO 20060445 A NO20060445 A NO 20060445A NO 20060445 L NO20060445 L NO 20060445L
Authority
NO
Norway
Prior art keywords
amisulpride
pharmaceutical composition
solid pharmaceutical
orodispersible
composition
Prior art date
Application number
NO20060445A
Other languages
English (en)
Norwegian (no)
Inventor
Gareth Lewis
Frederic Andre
Henri Da Cruc
Michel Denni
Jerome Migonneau
Agnes Ribardiere
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20060445L publication Critical patent/NO20060445L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20060445A 2003-07-09 2006-01-27 Fast farmasoytisk preparat omfattende amisulprid NO20060445L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308409A FR2857263B1 (fr) 2003-07-09 2003-07-09 Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
PCT/FR2004/001792 WO2005004860A2 (fr) 2003-07-09 2004-07-08 Nouvelle composition pharmaceutique solide comprenant de l'amisulpride

Publications (1)

Publication Number Publication Date
NO20060445L true NO20060445L (no) 2006-01-27

Family

ID=33522905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060445A NO20060445L (no) 2003-07-09 2006-01-27 Fast farmasoytisk preparat omfattende amisulprid

Country Status (14)

Country Link
US (1) US20060153925A1 (pt)
EP (1) EP1646379B1 (pt)
JP (1) JP2007516188A (pt)
KR (1) KR20060032628A (pt)
CN (1) CN1842331A (pt)
AU (1) AU2004255504A1 (pt)
BR (1) BRPI0412364A (pt)
CA (1) CA2529461A1 (pt)
FR (1) FR2857263B1 (pt)
IL (1) IL172814A0 (pt)
MX (1) MXPA06000332A (pt)
NO (1) NO20060445L (pt)
WO (1) WO2005004860A2 (pt)
ZA (1) ZA200600159B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894475B1 (fr) * 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
EP1935405A1 (en) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Orally disintegrating tablets
WO2010023690A2 (en) * 2008-08-28 2010-03-04 Torrent Pharmaceuticals Ltd. Prolonged release formulation of amisulpride
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
SG189298A1 (en) * 2010-11-08 2013-05-31 Colgate Palmolive Co Oral compositions containing microaggregates
FR3008900B1 (fr) * 2013-07-25 2018-03-30 Centre Nat Rech Scient Nanoparticules lipidiques multicompartimentees
CN107126422B (zh) * 2017-03-02 2020-07-07 河北龙海药业有限公司 一种氨磺必利片剂及其制备方法
AU2018378348B2 (en) 2017-12-05 2024-09-19 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
CA3084953A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
JP7233852B2 (ja) * 2018-04-17 2023-03-07 キョーリンリメディオ株式会社 変色が抑制された固形製剤
CN110613690A (zh) * 2018-06-19 2019-12-27 北京万全德众医药生物技术有限公司 一种氨磺必利口崩片及其制备方法
CN109010300A (zh) * 2018-10-24 2018-12-18 湖南洞庭药业股份有限公司 一种氨磺必利片及其制备方法
AU2020286441A1 (en) 2019-06-04 2022-01-06 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof
CN112089698A (zh) * 2020-10-23 2020-12-18 江苏阿尔法药业有限公司 氨磺必利片及其制备方法
CN115487161B (zh) * 2022-11-18 2023-03-03 山东则正医药技术有限公司 一种氨磺必利片的制备方法
TW202529747A (zh) * 2023-10-06 2025-08-01 美商Ｌｂ製藥股份有限公司 抗精神病藥劑之用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
ATE260646T1 (de) * 1996-04-16 2004-03-15 Novartis Consumer Health Sa Schnell zerfallende orale dosierungsform
FR2753639B1 (fr) * 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
DK1035834T3 (da) * 1997-12-05 2002-07-08 Alza Corp Osmotisk doseringsform omfattende en første og anden coating
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
KR20060032628A (ko) 2006-04-17
WO2005004860A3 (fr) 2005-04-14
CN1842331A (zh) 2006-10-04
FR2857263A1 (fr) 2005-01-14
JP2007516188A (ja) 2007-06-21
FR2857263B1 (fr) 2005-09-09
EP1646379B1 (fr) 2013-09-18
ZA200600159B (en) 2007-03-28
MXPA06000332A (es) 2006-03-30
US20060153925A1 (en) 2006-07-13
CA2529461A1 (fr) 2005-01-20
AU2004255504A1 (en) 2005-01-20
EP1646379A2 (fr) 2006-04-19
WO2005004860A2 (fr) 2005-01-20
BRPI0412364A (pt) 2006-09-05
IL172814A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
NO20060445L (no) Fast farmasoytisk preparat omfattende amisulprid
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
JP2005512997A5 (pt)
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
UY30537A1 (es) Formulaciones de flibanserina y metodo para fabricarlas
NO20064570L (no) Farmasoytiske preparater
NZ600129A (en) Capsule formation of pirfenidone and pharmaceutically acceptable excipients
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
DE60121570D1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
UY27598A1 (es) Composiciones farmacéuticas de derivados de taxano oralmente activos que tienen biodisponibilidad mejorada
SE0102276D0 (sv) Device and method for the administration of a medicament
WO2001022791A8 (en) Controlled release compositions comprising nimesulide
MX9308188A (es) Glucomanano de konjac facilmente disponible, como un excipiente de liberacion sostenida.
DE60313359D1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
WO2002024203A3 (en) Controlled release formulations for oral administration
HRP20080252T3 (hr) Oralni antimikrobni farmaceutski pripravci
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
DE602005008128D1 (de) Cytisinehaltiges Arzneimittel
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
DE60024439D1 (de) Enalaprilmaleat enthaltende, stabile, feste arzneimittel
CL2007001675A1 (es) Procedimiento de preparacion de composiciones farmaceuticas en comprimidos, de desintegracion rapida y sustancialmente exentos de cristales del agente activo provenientes de la fabricacion, que comprende formar una masa granulada a partir del agente

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application